DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 205 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $610,680 | +40.6% | 41,346 | +23.0% | 0.00% | 0.0% |
| Q2 2023 | $434,305 | +158.8% | 33,615 | +96.5% | 0.00% | – |
| Q1 2023 | $167,800 | -83.4% | 17,105 | -82.0% | 0.00% | -100.0% |
| Q4 2022 | $1,011,874 | -16.2% | 95,101 | -17.8% | 0.00% | 0.0% |
| Q3 2022 | $1,207,000 | -71.5% | 115,684 | -65.6% | 0.00% | -71.4% |
| Q2 2022 | $4,232,000 | +249.2% | 336,151 | +200.4% | 0.01% | +250.0% |
| Q1 2022 | $1,212,000 | -73.3% | 111,890 | -65.3% | 0.00% | -60.0% |
| Q4 2021 | $4,540,000 | – | 322,690 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |